Phase II of Lenvatinib Plus Toripalimab for Advanced HCC

Clinical trial NCT03919383 · WITHDRAWN

Trial details

NCT number: NCT03919383
Sponsor: Sun Yat-sen University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-04-15
Primary completion: 2019-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.